Axiomed Expands Series D to $20 Million

Axiomed Expands Series D to $20 Million


Garfield Heights, OH--Axiomed Spine Corporation has expanded its Series D venture capital financing round to $20 million. The Company recently received a CE mark for its Freedom® Cervical Disc, enabling it to be sold in the EU. The Company's Freedom® Lumbar Disc is already on the market in the EU.
The additional financing will enable the Company to further its efforts to obtain U.S. regulatory approval for the Freedom Lumbar® Disc in the U.S. The Company is concluding a pivotal clinical trial of the lumbar disc and hopes for FDA clearance in 2014. Read more...

Find Out More About ESP

Staff Photo

Jonathan Murray manages the investment in Axiomed